MiniMed Group, Inc. Common Stock

NASDAQ:MMED

Medical - Care Facilities

Healthcare
$16.99 +2.63%

+$0.40 today

Market cap
$4.78B
Beta
-3.63
P/E (TTM)
-14.2
EPS (TTM)
-$1.91
52W Low $10.65High $20.48

Volume 4.70M

Average 0.95M

MMED Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

MiniMed Group, Inc. Common StockNASDAQ: MMED

Gross Margin · Q1 FY2026 · quarter ended Jul 2026

Gross margin at 55.2%

Gross margin was 55.2% in Q1 FY2026. On a trailing-twelve-month basis it was 53.8%. Over 3 fiscal years it narrowed by 4.1 pp.

Context

  • Gross margin widened in 0 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJul 2026
55.2%-2.2 pp QoQ
Last fiscal yearApr 2026
54.2%-2.0 pp YoY
LTMJul 2026
53.8%— YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter———
1 year-2.0 pp——
3 years-4.1 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
54.2%
Year-over-year change
-2.0pp

Gross Margin vs competitors

How MMED compares with its peers on the latest reported figures

  • MMED's LTM Jul 2026 gross margin of 53.8% is the 6th highest of the 7 companies compared; the peer median is 59.8%.
  • Over three fiscal years its change of -4.1 pp compares with a peer median of +0.1 pp.
MMED Competitors Peer median
Gross Margin for MMED and competitors
Company Period LTM level YoY 3-year change
PODDInsulet CorporationLTM Jun 202671.1% +0.3 pp+9.9 pp
MDTMedtronic plcLTM Jul 202666.7% +3.3 pp-0.7 pp
DXCMDexCom, Inc.LTM Jun 202662.5% +3.7 pp-4.6 pp
BBNXBeta Bionics, Inc.LTM Mar 202657.2% +3.2 pp-44.6 pp
TNDMTandem Diabetes Care, Inc.LTM Mar 202654.9% +8.4 pp+0.8 pp
MMEDMiniMed Group, Inc. Common StockLTM Jul 202653.8% —-4.1 pp
SENSSenseonics Holdings, Inc.LTM Mar 202652.1% +44.9 pp+28.1 pp
MMEDVMiniMed Group, Inc.—— ——
Peer median (excluding MMED) 59.8%+3.5 pp+0.1 pp

Competitors are the stored peer set for MMED. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Apr 2023
FY2023
Apr 2024
FY2024
Apr 2025
FY2025
Apr 2026
Revenue2.25B2.47B2.72B3.1B
Cost of Revenue937M1.03B1.19B1.42B
Gross Profit1.31B1.44B1.53B1.68B
Gross Margin58.3%58.2%56.2%54.2%
Research & Development429M437M438M448M
Selling, General & Admin960M1.06B1.13B1.18B
Operating Expenses1.38B1.51B1.73B1.63B
Depreciation & Amortization115M129M143M156M
EBITDA39M59M107M205M
EBITDA Margin1.7%2.4%3.9%6.6%
Operating Income(69M)(69M)(202M)49M
Operating Margin-3.1%-2.8%-7.4%1.6%
Interest Income0000
Interest Expense0000
Other Income / Expenses(7M)(1M)(1M)(236M)
Income Before Tax(76M)(70M)(203M)(187M)
Pre-Tax Margin-3.4%-2.8%-7.5%-6.0%
Income Tax Expense16M38M48M128M
Net Income(96M)(112M)(250M)(331M)
Net Margin-4.3%-4.5%-9.2%-10.7%
EPS (Basic)(0.34)(0.40)(0.89)(1.29)
EPS (Diluted)(0.34)(0.40)(0.89)(1.29)
Weighted Avg Shares280.81M280.81M280.81M256.6M
Weighted Avg Shares (Diluted)280.81M280.81M280.81M256.6M

MiniMed Group, Inc. Common Stock

NASDAQ:MMED

Intrinsic Alpha fair value

Locked

Current Price

$16.99

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.